Fri, 29 December 2017
In the closing act of the Industry Focus Awards, the cast revisits Foolish listener emails before pitching their nominees for most likely to succeed and the infamous participation award. |
Thu, 28 December 2017
Notable quotes and M&A take the stage as the next two categories up for grabs. Find out who went home with a prestigious IF Award in hand. |
Wed, 27 December 2017
The show must go on! In this episode, the cast doles out their awards for the next two categories: best fact and most valuable player. |
Tue, 26 December 2017
Happy holidays, Fools! This year, the Industry Focus cast is rolling out the red carpet for some of their favorite stocks with the first annual Industry Focus Awards ceremony. The first two categories for your consideration: biggest PR blunder and rookie of the year. |
Fri, 22 December 2017
We hit the biggest stories of the year — iPhone X, net neutrality, AR/VR, and Verizon buying Yahoo — and talk about how they may impact 2018. |
Thu, 21 December 2017
Top Energy and Industrials Headlines From 2017. We look back across various events of the past year in our sector. From arrests of Volkswagen executives to GE’s 40% drop, 2017 has been a big year. |
Wed, 20 December 2017
Repeal and replace wasn't the only healthcare story this year! Critical policy changes, revolutionary new medicines, and M&A also sent healthcare stocks on a wild ride in 2017. |
Tue, 19 December 2017
Looking back on a busy year, the cast recaps some of the biggest stories and developments in the sector. Slack: Where work happens. Find out why at slack.com. |
Mon, 18 December 2017
Financials takes a look back at the five biggest news stories of 2017 and what they mean to investors. |
Fri, 15 December 2017
We're excited for 2018. Why? We've got tax code changes impacting the books of big tech, plus the next phases of the cable revolution, and the continued rise of e-sports. |
Thu, 14 December 2017
Alternative fuels are still a long way from being ubiquitous but some are gaining steam thanks to a few key players. We discuss what constitutes an alternative fuel, why commercial and heavy goods transport is the gateway to alternatives adoption, and stocks investors may want to consider. Today the show was sponsored by Harrys.com/Fool |
Wed, 13 December 2017
Celgene and bluebird bio report a stunning success in multiple myeloma, Juno Therapeutics takes it on the chin despite positive data, and Spark Therapeutics suffers in its showdown with BioMarin in hemophilia. |
Tue, 12 December 2017
Subscription-box services have grown incredibly popular in the past few years, and Stitch Fix is the latest company based on this business model to go public. With almost $1 billion of revenue in 2017, we dive into this fast-growing company and what investors need to know about its data-centric approach to selling apparel. To get a limited edition holiday shave set while supplies last, go to Harrys.com/fool. |
Mon, 11 December 2017
Industry Focus: Financials takes a deep dive into Goldman Sachs and Morgan Stanley’s business models, valuation, and future growth potential. |
Fri, 8 December 2017
These tech unicorns have long been the subject of IPO speculation. But for all that buzz, are any of them actually good businesses to own long-term? |
Thu, 7 December 2017
UPS, FedEx, and USPS will deliver an estimated two billion packages during the holiday season. We discuss how they make this happen, their past and current struggles to do so profitably, and what this all means for retailers, consumers, and investors. |
Wed, 6 December 2017
The tax bill includes fine print that could make biopharma companies pay more in taxes than expected. Plus, CVS Health cozies up to Aetna and Apple takes aim at heart disease. |
Tue, 5 December 2017
Cut costs, streamline operations, and acquire growth. That has been the recipe for success for 3G Capital (and frequent partner Warren Buffett), but as headwinds mount for packaged food and beverages, Kraft Heinz needs to find other avenues for growth. The cast also looks at Etsy and its trajectory under new CEO Josh Silverman. |
Mon, 4 December 2017
Financials takes a deep dive into BofI Holding’s business model, competitive advantages, valuation, and potential future growth catalysts. |
Fri, 1 December 2017
We take a look at a few tech products on holiday shopping lists -- Nintendo Switch, Fitbit Ionic, and Xbox One S/X -- and talk about what their popularity really means for the companies that make them. |
Thu, 30 November 2017
Nebraska Public Service Commission voted 3-2 to approve an alternative route for the Keystone XL pipeline through the state. We discuss potential implications of Keystones operator TransCanada, and what the decision might mean for investors. Ahead of the OPEC meeting in Vienna, we debate the rumors and conjecture around the assembly. |
Wed, 29 November 2017
Canopy Growth co-founder Bruce Linton is interviewed about the company’s strategy for medicinal and recreational marijuana in Canada and beyond. |
Tue, 28 November 2017
Early numbers are in for the Black Friday weekend with strong growth over last year. That momentum has even extended to brick-and-mortar retailers, which saw only small traffic declines during the busy period. Find out why department stores are feeling confident about the quarter, and what investors should watch as they head into the final month of the year.
Slack: Where work happens. Find out why at slack.com. |
Mon, 27 November 2017
Financials sets the record straight on common money myths involving topics ranging from investing in stocks to using credit cards. |
Wed, 22 November 2017
You know the market is risky and you shouldn't own just one or two stocks, but you're probably wondering how many stocks you should own. In today's episode, we dig into diversification to help you build a better portfolio. |
Tue, 21 November 2017
While AT&T and Time Warner investors prepare themselves for a tough legal battle with the Justice Department to close their merger, competitors are circling the valuable media empire that could be going up for sale at Twenty-First Century Fox. |
Mon, 20 November 2017
Financials looks at the two tax reform bills currently making their way through Congress, the differences between them, and the likely winners and losers of tax reform. |
Fri, 17 November 2017
Roku's first report as a publicly traded company couldn't have gone better. With a second look at their books, are we more sold on the long-term viability of the streaming company? Editor's note: In the show, we mistakenly said that 1/3 of Roku's platform revenue comes from licensing. That 1/3 portion of the platform revenue is actually from content distribution, the licensing portion is much smaller. Thanks to Harry’s for supporting Motley Fool. Harry’s will give you their trial shave set for FREE when you sign up at Harrys.com/FOOL - just pay for shipping! |
Thu, 16 November 2017
The U.S is increasingly being powered by cheap natural gas and the deployment of pipeline infrastructure is ensuring this remains the case for years to come. In this show we discuss why the commodity is growing in popularity, the billions of dollars being spent transporting it across the country, and investment opportunities in the industry. |
Wed, 15 November 2017
A flurry of news has investors clamoring to add Nektar Therapeutics to their portfolios. Plus, we explain why investors are disappointed by Loxo Oncology’s good news and how a new smart pill could change medicine forever. |
Tue, 14 November 2017
Shares of the #2 toy company and casual dining chain are both up double digits thanks to buyout rumors. For Mattel, the potential deal with Hasbro would create a dominant player in the toy industry. Meanwhile, a private equity firm with significant restaurant experience is courting B-Dubs. The team also takes a look at Canada Goose, one of the best-performing IPOs of the year. Thanks to Harry’s for supporting The Motley Fool. Get your Free Trial Set -- go to Harrys.com/fool. |
Mon, 13 November 2017
Financials looks at robo-advisors, the automated substitute for financial advisors that has surged in popularity. |
Fri, 10 November 2017
After missing on revenue, earnings, and users, shares of Snap got pummeled following the company's Q3 earnings release. We work through the release, talk about the company's transition to auction-based ad sales, and check in on the Spectacles hardware segment. |
Thu, 9 November 2017
Utilities have historically been classified as safe and boring but the industry is changing and there are some potentially exciting opportunities in the often overlooked segment. |
Wed, 8 November 2017
The much-maligned company is making progress on its restructuring plan, but it's not out of the woods yet. Plus, why Keryx Pharmaceuticals shares tumbled despite winning an FDA approval that more than doubles its addressable market. |
Tue, 7 November 2017
In 2014, regulatory opposition forced Sprint to give up on its plan to acquire T-Mobile. Three years later, the two companies returned to the negotiating table, coming close to finalizing an agreement before the deal fell apart once again. What happened? And what lies ahead for the No. 3 and 4 wireless providers? |
Mon, 6 November 2017
Financials looks at the new Federal Reserve chair, rising interest rates in the U.K, and the end of the CFPB class action rule. |
Fri, 3 November 2017
Great earnings releases from Microsoft and Amazon highlight one thing in particular -- the cloud business is booming for both tech giants. |
Thu, 2 November 2017
2017 hasn’t been kind to GE so far. Three months in we discuss the moves new CEO John Flannery is making to right the business, rumors around the November 13th meeting, and give our bull and bear cases for the stock. |
Wed, 1 November 2017
Beer, wine, and spirits Goliath Constellation is acquiring a 10% stake in marijuana stock Canopy Growth, plus why CVS Health is eyeing Aetna, and how one fast-growing upstart is fighting back at colon cancer. |
Tue, 31 October 2017
The Toys “R” Us bankruptcy filing in September sent waves through the industry as toy companies cut shipments to the retailer and adjusted their forecasts ahead of the holiday shopping season. However, the latest earnings results from Mattel and Hasbro paint a picture of two industry leaders with very different outlooks. |
Mon, 30 October 2017
Financials looks at statistics about emergency savings, credit cards, retirement saving, stock investing, and homeownership. |
Fri, 27 October 2017
AMD and Twitter both beat expectations with their quarterly numbers, so why is the social media company flying while shares of the semiconductor company get pummeled? FreshBooks.com/FOOL and enter MOTLEY FOOL in the “How Did You Hear About Us?” section |
Thu, 26 October 2017
We discuss U.S. manufacturing, policy making, and how technology will unlock efficiencies in the oil and gas industry with Mark Mills. Mark has a long and illustrious career as a policy advisor, fund manager, and physicist. |
Wed, 25 October 2017
A scary sell-off in Celgene and Ionis Pharmaceuticals shares may have you thinking "sell", but there are good reasons why you shouldn't let what's spooking other investors shake you out of your stock too. |
Tue, 24 October 2017
Up over 70% in the past year, the iconic newspaper has enjoyed a major boost in readership thanks to the current presidential administration. Meanwhile, Blue Apron struggles to build momentum as meal kit rival HelloFresh prepares for its IPO. Thanks to Freshbooks for supporting the Motley Fool. Get a 30-day free trial by going to FreshBooks.com/FOOL and enter “MOTLEY FOOL” in the “How Did You Hear About Us?” section. |
Mon, 23 October 2017
Financials takes a look at bank earnings, important metrics, and catalysts that could move bank stocks higher. |
Fri, 20 October 2017
We wrap up pitch week with discussions of IBM, Netflix, and Mindbody. If you want the whole list of pitch week stocks, email industryfocus@fool.com! |
Thu, 19 October 2017
Three Motley Fool contributors pitch General Motors, NV5, and Transocean as stocks investors might want to watch. |
Wed, 18 October 2017
Novocure, Precision Medicine, and Celgene are three top healthcare stocks. The team discusses their business models and biggest risks in this edition of “Pitch Week.” |
Tue, 17 October 2017
“Pitch Week” continues on Industry Focus as our Foolish contributors share their takes on Under Armour, Dave & Buster’s, and Tractor Supply Co. Thanks to Harry’s for supporting the Motley Fool. Get your free trial set -- go to Harrys.com/fool. |
Mon, 16 October 2017
We kick off "Pitch Week" with a look at payment companies Mastercard and Square, and wrap the show with a breakdown of why Warren Buffett's Berkshire Hathaway has been such a good business to own. |
Fri, 13 October 2017
Netflix got a nice bump after announcing price increases to several of its service tiers – what might the increases mean for the company’s top line and what should investors be paying attention to ahead of the company’s earnings report next week? |
Thu, 12 October 2017
The U.S. has a huge number of investment opportunities in the well-developed energy industry. We discuss why the U.S. oil and gas sector has developed the way it has, some complexities in investing in overseas energy companies, and a few stocks with foreign flare you might want to consider. |
Wed, 11 October 2017
Mylan launches a generic "at-risk" and Flexion's big drug opportunity becomes clearer. Editor's note: Mylan's drug was mistakenly referred to in the episode as a biosimilar. Copaxone, however, was approved under an NDA, not a BLA, so Mylan's copycat is a generic, not a biosimilar. |
Tue, 10 October 2017
We look at the latest quarterly earnings from some of the top performers in the alcohol and restaurant industries. Slack: Where work happens. Find out why at slack.com. |
Mon, 9 October 2017
Financials takes a look at share buybacks, dividends, and other ways of returning capital to shareholders. |
Fri, 6 October 2017
Now that we have a sense of Roku's valuation, what do we think of it? That, plus a rundown on all the cool new devices Google showed off earlier this week and their impact on the smartphone, smart home and camera markets. Get $25 off your first purchase at http://bombfell.com/fool |
Thu, 5 October 2017
Tesla missed Q3 Model 3 production targets by 83%. We debate how concerned investors should be, some good news from the update, and a potentially exciting development on the horizon. Thanks to Bombfell for supporting The Motley Fool. Get $25 off your first purchase at http://bombfell.com/fool |
Wed, 4 October 2017
Wondering if you can buy, sit back, and collect money on top dividend stocks Johnson & Johnson, AbbVie, and Pfizer? You've come to the right place! In today's episode, we offer up insight into the risk and reward associated with owning these three dividend darlings. |
Tue, 3 October 2017
We dive into the high-end corner of the retail industry with one of the most famous luxury brands in the world: Tiffany. Its signature blue boxes have delighted people around the world, and new leadership is now looking ahead to the challenges posed by changing consumer tastes, especially among younger shoppers. We also look at the latest acquisitions from Coca-Cola and Wal-Mart. |
Mon, 2 October 2017
President Trump is interviewing candidates to replace Janet Yellen atop the Federal Reserve. In this episode of Industry Focus: Financials, we dig into the two types of candidates he's considering for the position, and how that will impact the central bank's policies. |
Fri, 29 September 2017
Investors may soon be able to claim a stake in rapper Eminem's music catalog, thanks to a new company Royalty Flow and the JOBS Act. We run through what's been going on in the equity crowdfunding and mini-IPO space, and how these types of investment opportunities are very different than investing in the stocks we normally talk about. |
Thu, 28 September 2017
We debate the potential implications of the ITCs recommendation for solar import restrictions, the recent rally in oil prices, and the news that GE is selling its Industrial Solutions business. |
Wed, 27 September 2017
Unpacking Axovant Sciences big Alzheimer’s disease disappointment, plus Pfizer accuses Johnson & Johnson of unfairly increasing healthcare costs. |
Tue, 26 September 2017
Between its upcoming ESPN and Disney-branded services, the company will give viewers access to 10,000 live sporting events, 500 films, and over 7,000 television episodes. Traditional pay-TV subscriber numbers are on the decline, and CEO Bob Iger sees this streaming transition as his last major priority before retirement. |
Mon, 25 September 2017
Data center REITs promise ever-growing dividends from a portfolio of data center assets located all around the world, but growing piles of data don't necessarily lead to extreme rewards for shareholders. |
Fri, 22 September 2017
Alarm.com, Impinj, and Paycom aren't household names yet, but these tech-savvy upstarts are transforming billion dollar markets and that could make them savvy stocks to buy. Thanks to Harry’s for supporting Motley Fool. Get your Free Trial Set – go to Harrys.com/fool |
Thu, 21 September 2017
Auto sales have declined 2% this year after sales broke records in 2016, leading many commentators to speculate whether the U.S. has reached peak auto. However, one area of the market – SUV’s, light trucks, and crossovers – continues to demonstrate growth. Thanks to Harry’s for supporting Motley Fool. Get your Free Trial Set – go to Harrys.com/fool |
Wed, 20 September 2017
We rip open the mailbag and answer "what gives with interim clinical trials?", "how can drugmakers use patents to stiff-arm generics?" and "why aren't pharmacies cashing in on baby boomers?" |
Tue, 19 September 2017
Chegg is leading its corner of the classroom with a wide variety of student services, including college applications, textbook materials, and online tutoring. Meanwhile, 2U is acting as a pioneer for online education by creating graduate programs with some of the most prestigious universities in the country. Both of the companies are enjoying double-digit annual growth rates and stand to gain as technology takes on an increasing role in classrooms around the world. |
Mon, 18 September 2017
The team talks about how the insurance industry works and how health insurance differs substantially from other types of insurance. With information about evaluating supplemental health insurance policies, planning for Medicare at age 65, and managing the transition from work-related coverage to Medicare, this program will tell you what you need in order to make a more informed decision for your financial and health situation |
Fri, 15 September 2017
Edge-to-edge display? Check. Wireless charging? Check. Facial recognition components? Check. The iPhone X is gorgeous, but what does its release timing mean for Apple’s financials over the next few quarters? We dig into that and Apple’s other upcoming products. |
Thu, 14 September 2017
After years of being dubbed “death traps” for investors the Airlines industry is having something of a renaissance. We discuss which of the big four U.S. national carriers is the better buy for investors today. |
Wed, 13 September 2017
A new study concludes it costs $757 million to develop a new cancer drug, but is that the only reason why drugmakers charge sky-high drug prices or are other reasons to blame too? |
Tue, 12 September 2017
In a strange twist, the newest retail store from Nordstrom will carry no inventory. Instead, the company hopes a unique menu of services will provide a rich enough experience to connect with shoppers – a trend that is growing quickly in the brick-and-mortar world. The cast also looks at how Starbucks is faring under the new leadership of Kevin Johnson. |
Mon, 11 September 2017
It’s not always an easy decision, and in most cases you should do some planning first, but there are times when you’re doing the right thing in quitting your job. Of course there’s a difference between wanting to quit and needing to quit and some things you should do before giving notice. |
Fri, 8 September 2017
The streaming service is planning to go public soon and we have our hands on their filing with the SEC! We run through the company's books, talk about the streaming space, and take a look at the company's long-term prospects. |
Thu, 7 September 2017
Energy Secretary Rick Perry announced the Department of Energy is releasing 500,000 barrels of oil from the Strategic Petroleum Reserves. We discuss the impact and importance of the move. |
Wed, 6 September 2017
Promo: Big-cap biopharma could come knocking if Juno Therapeutics’ next-generation CAR-T is safer than its competitors, and Medtronic's already investing billions in Mazor Robotics, a maker of surgical robots. Sponsored link: http://www.casper.com/fool Code: fool. |
Tue, 5 September 2017
Amazon has already begun to weaponize its Whole Foods stores, and we look at how competing retailers like Kroger and Costco are feeling the pressure. Meanwhile, the major dollar store chains are facing their own challenges from larger retail rivals. Thanks to Casper for supporting the podcast. Save $50 on a mattress at http://www.casper.com/fool, code “fool”.
|
Sat, 2 September 2017
IF brings you stories and coverage of different sectors of the stock market every day, but what trends are the hosts most excited about, and what stocks are on their watch lists? We bring everyone into the studio for this bonus episode to answer these questions and introduce the new Thursday host Sarah Priestley. |
Fri, 1 September 2017
We toss around some terms week-to-week and don't always do the best job explaining them in-depth. Today, we dust off our college accounting books to talk about the difference between capitalizing and expensing a purchase, what deferred revenue is, and why operating leverage is a beautiful thing. |
Thu, 31 August 2017
In the ongoing devastation of Hurricane Harvey headlines are surfacing about the storms impact on US oil and Gas -- on this episode we discuss potential outcomes for the industry, and touch on the recent appointment of a new CEO for GE. |
Wed, 30 August 2017
The FDA approved the world's first CAR-T therapy on Wednesday, one month ahead of schedule, and only days after Gilead Sciences announced it’s buying CAR-T powerhouse Kite Pharma in a deal valued at $11.9 billion.
|
Tue, 29 August 2017
Join us for a look at the incredible growth of e-sports and the opportunity it presents to various industry stakeholders, including game publishers, content networks, and the players themselves. We also discuss the recent legal troubles at iRobot. |
Mon, 28 August 2017
Every industry has its shining lights, and the bank industry is no different. In this episode of Industry Focus: Financials edition we discuss the top bankers in the modern era, including Jamie Dimon, Richard Davis, Robert Wilmers, and more. |
Fri, 25 August 2017
Two years ago we tossed out a terrible ballpark on the revenue Apple Music might be able to bring in for the tech giant. Today we talk about that mistake and how to set yourself up to make better projections. Thanks to Harry’s for supporting Industry Focus. Get your free trial set – go to Harrys.com/fool |
Thu, 24 August 2017
Energy: We Finally Learned That Leveraged Oil Stocks Without a Cost Advantage Probably Are Bad Investments
Everyone makes mistakes, the important thing is to learn from them. |
Wed, 23 August 2017
We said what? Let’s face it, sometimes our predictions miss the mark, and with Rite Aid and Opko Health, they missed the mark by a lot. Here’s what we said, why we said it, and what we learned from our mistakes.
|
Tue, 22 August 2017
We said what?!? That is our theme for Industry Focus this week, and we continue the discussion with missed calls on Wal-Mart’s Jet.com acquisition and the 2,000 stores Amazon was supposed to open in the next several years. Thanks to Harry’s for supporting the Motley Fool. Get your Free Trial Set -- go to Harrys.com/fool. |
Mon, 21 August 2017
Everyone makes mistakes. But not many of us air them publicly. That's the theme of this week's Industry Focus, starting with our prediction in 2015 that concerns about Wells Fargo's cross-selling culture were much ado about nothing.
|
Fri, 18 August 2017
We run through recent wearables market data from Strategy Analytics, check in on the major players, and talk about the long-term outlook for Fitbit. |
Thu, 17 August 2017
A solar eclipse occurs Monday -- what that means for solar producers may surprise you. |
Wed, 16 August 2017
With a slate of promising drugs hitting the market and in its development pipeline, Regeneron Pharmaceuticals is becoming one of biotechs most important players. |
Tue, 15 August 2017
For several years, Procter & Gamble has been spinning off low-priority brands and cutting costs to streamline its business. But with little to show for those efforts, billionaire Nelson Peltz wants a seat at the table. Meanwhile, a slow summer blockbuster season is taking a major toll on theater operators. |
Mon, 14 August 2017
Business development companies are undergoing a sea change as the asset class becomes more institutionalized. |
Fri, 11 August 2017
Snap's quarterly update was... uninspiring. On this show, we talk about the updated user counts, ask some questions on engagement metrics, and run through the new financials. |
Thu, 10 August 2017
Fracking has been the oil industry buzzword for years, here’s what the process actually means. |
Wed, 9 August 2017
Scotts Miracle Gro could be the best marijuana stock to buy, while Illumina could be the best bet to capitalize on DNA-based medicine. |